CB-59 and CB-81, two small-molecule tau aggregation inhibitors with CNS drug-like properties Sep. 6, 2018
Phase I/II results with pegzilarginase in arginase deficiency support upcoming pivotal trial Sep. 6, 2018
Phase III study of NeoCart in patients with knee cartilage damage does not meet the primary endpoint Sep. 6, 2018
PLAG1 overexpression induces Wilms tumor formation and correlates with early relapse in patients Sep. 6, 2018
RSS